New Delhi — Air India has launched mandatory screening of all pilots across the group for prohibited substances and medications, expanding its safety checks following a recent incident involving a flight from Phuket to Delhi.
The screening program began Thursday and applies to all pilots within the Air India group, according to a communication sent to flight crews.
Air India said it has long relied on the professionalism, skill and commitment to safety of its pilots and other employees, adding that preserving public confidence remains a priority.
“Many of you have recently reached out to share the same sentiment,” the airline said in the communication.
The Tata Group-owned carrier said it already complies with requirements established by India’s Directorate General of Civil Aviation, which are broadly in line with practices in major aviation markets such as Europe and the United States.
However, Air India said it had decided to introduce additional screening beyond those requirements.
“Accordingly, we have decided to undertake a full screening of all Group pilots for any substances or medications that are not permitted under prevailing regulations,” the airline said.
Testing will be mandatory and conducted during training sessions at Air India’s Gurugram academy, after flights at Flight Briefing Centres and company offices, and at designated locations at pilots’ operating bases.
Air India said the expanded testing reflects its effort to maintain high standards of safety and professionalism while reassuring passengers and other stakeholders.
The airline also instructed pilots to contact their chief pilot or base manager with questions about the screening process.
The move follows an incident last week involving an Air India flight from Phuket to Delhi that experienced a sudden loss of altitude. According to sources, the pilot in command had been taking medication for difficulty sleeping. (Source: IANS)
